Cargando…
Immune checkpoint inhibitors in liver transplant: a case series
BACKGROUND: Immune checkpoint inhibitors (ICIs) in the setting of liver transplant (LT) pose a risk of rejection and hold unclear benefit in both the neoadjuvant (pre-transplant) and post-transplant salvage setting. In the pre-transplant setting, neoadjuvant ICIs may serve as a bridge to LT by downs...
Autores principales: | Rudolph, Mark, Shah, Shimul A., Quillin, Ralph, Lemon, Kristina, Olowokure, Olugbenga, Latif, Tahir, Sohal, Davendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186520/ https://www.ncbi.nlm.nih.gov/pubmed/37201081 http://dx.doi.org/10.21037/jgo-22-922 |
Ejemplares similares
-
Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series
por: Mayor Ibarguren, Ander, et al.
Publicado: (2021) -
The efficacy of immune checkpoint inhibitors in thoracic malignancies
por: Remon, Jordi, et al.
Publicado: (2021) -
Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review
por: Thouvenin, Laure, et al.
Publicado: (2021) -
Severe Diarrhea in the Setting of Immune Checkpoint Inhibitors
por: Kuo, Jean R., et al.
Publicado: (2018) -
Immune checkpoint inhibitor-related myocarditis: an illustrative case series of applying the updated Cardiovascular Magnetic Resonance Lake Louise Criteria
por: Wintersperger, Bernd J, et al.
Publicado: (2022)